Cantor Fitzgerald Reiterates Overweight on Kura Oncology

Kura Oncology, Inc. 0.00% Post

Kura Oncology, Inc.

KURA

10.68

10.63

0.00%

-0.47% Post
Cantor Fitzgerald analyst Li Watsek reiterates Kura Oncology (NASDAQ: KURA) with a Overweight.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via